October 21st 2024
Results from the RAMP 201 clinical trial are promising for patients with recurrent low-grade serous ovarian cancer.
October 21st 2024
October 18th 2024
October 17th 2024
October 16th 2024
October 13th 2024
October 6th 2024
September 28th 2024
September 12th 2024
October 14th 2024
October 12th 2024
October 11th 2024
October 4th 2024